Modulating the antiproliferative activity and cardiotoxicity of doxorubicin with melatonin and PPARy-ligands
Cancer is one of the leading causes of death worldwide and only modest progress has been achieved in decreasing the mortality and incidence of this disease. Combined therapy in cancer treatment is one of the main approaches used to treat this disease and enhance the therapeutic index. Doxorubicin (D...
| Main Author: | |
|---|---|
| Published: |
University of Reading
2011
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.558781 |